New data shows benefit of drug combination for metastatic castration resistant prostate cancer
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for
Read more
Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than
Read more